Growth fund research profile
Faering Capital is a growth investor focused on Indian businesses with durable consumer, financial-services and healthcare demand. Its public portfolio shows a concentrated approach across consumer brands, affordable finance, insurance and healthcare platforms.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Faering Capital uses a growth approach across Consumer, fin services, health.
Current evidence
Faering’s current AIF disclosures list India Evolving Fund III, Growth Fund III and International Growth Fund III. The IFC’s portfolio disclosure, updated for January 2025, names Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit, Nykaa and WheelsEMI among Fund III investees.
Strategy
Growth
Sector focus
Consumer, fin services, health
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Faering’s current AIF disclosures list India Evolving Fund III, Growth Fund III and International Growth Fund III. The IFC’s portfolio disclosure, updated for January 2025, names Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit, Nykaa and WheelsEMI among Fund III investees.
Investor questions
Faering Capital is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Growth, with a sector focus of Consumer, fin services, health. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Faering Capital in the reviewed public sources: Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit, Nykaa, WheelsEMI. It does not represent a complete current portfolio unless the manager has published one.
The manager’s portfolio page identifies Fund III at $218M and names PB Health, Vistaar Finance, Hangyo, Bakingo, Vastu Housing Finance, Go Digit and smallcase. The public record does not disclose an audited fund-level return or full exit history. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: Fund III capital raised is shown by the GP at $218M; earlier materials and directory records describe a broader platform around this vehicle.. Public terms or access information: Growth-stage investments in consumer, financial services and healthcare businesses. Current cheque, ownership and reserve terms are not consistently public.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Aditya Parekh, Sameer Shroff. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Current vehicle-level terms beyond disclosed AIF registrations and fund-level returns are not publicly disclosed..
2025-01-01: Faering’s current AIF disclosures list India Evolving Fund III, Growth Fund III and International Growth Fund III. The IFC’s portfolio disclosure, updated for January 2025, names Plum, Anthem Biosciences, BookMyForex, CAMS, Finova Capital, Go Digit, Nykaa and WheelsEMI among Fund III investees.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.